Navigation Links
Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables
Date:4/9/2009

e period in the prior year. The increase in SG&A in the fourth quarter of 2008 was in line with the increased business activity in 2008. In particular, payroll and bonus, higher consulting fees, travel and other expenses drove the year-over-year increase.

Net expenditures on research and development expenses for the fourth quarter of 2008 were $359,000, compared to $354,000 in the same period of 2007. The R&D expenses in the quarter are mainly incurred for the advancement of its vaccine candidates in the pre-clinical development pipeline, including Sinovac's vaccine against EV 71 and its human rabies candidate.

Operating income was $3.1 million for the fourth quarter of 2008, compared to $3.3 million in the same period of 2007. The year-over-year variance in operating income reflected relatively moderate higher expense in the fourth quarter.

Net income for the fourth quarter of 2008 included $284,000 in income tax recovery, $327,000 interest and other income and $1.4 million of minority interest. Net income for the same period of 2007 included $184,000 of interest and financing expenses, $42,000 of income taxes expense, $111,000 other expenses and $965,000 of minority interest. Net income for the fourth quarter of 2008 was $2.4 million, or $0.06 per diluted share, compared to $2.0 million, or $0.05 per diluted share, in the same period of 2007.

As of December 31, 2008, Sinovac's cash and cash equivalents totaled $32.9 million, compared to $20.5 million as of September 30, 2008. The 60.4% increase in cash and cash equivalents compared to the third quarter of 2008 was primarily attributable to improved accounts receivables collection.

Recent Developments

Following the completion of a large scale, post-approval marketing study, the safety and immunogenicity of Sinovac's seasonal influenza vaccine, Anflu, was analyzed and reviewed by 18 provincial and
'/>"/>

SOURCE Sinovac Biotech Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related biology technology :

1. Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results
2. Sinovac to Host Conference Call to Report Fourth Quarter and Full Year 2008 Financial Results
3. Sinovac Biotech Co. Ltd., Sinovacs Beijing Subsidiary, Obtains High-Tech Enterprise Status
4. Sinovac Receives GMP Certification for its New Filling and Packaging Production Facility
5. Sinovac Enters Veterinary Vaccine Market with Inactivated Rabies Vaccine
6. Sinovac Releases Statement on Healive Vaccine Suspension
7. Sinovac Reports Third Quarter 2008 Unaudited Financial Results
8. Sinovac Named to Deloitte Technology Fast 50 China
9. Sinovac to Participate in Two Upcoming Investor Conferences
10. Sinovacs Credit Rating Upgraded to AAZ, Second Highest Rating
11. Sinovac Biotech Holds 2007 Annual General Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/14/2014)... Canada (PRWEB) July 14, 2014 ... executives from across the clinical trials space, representing ... eCongress webinar series entitled “Optimizing Patient Participation in ... eCongress kicked off with internationally renowned R&D expert, ... Keynote address on Reinventing Drug Development through Patient ...
(Date:7/13/2014)... 2014 Deep Research Report on Global and China ... on the current state of the Nano Silver industry ... basic overview of the industry, including definitions, applications and ... market analysis are provided with a focus on history, ... comparison between the international and Chinese situation is also ...
(Date:7/11/2014)... 11, 2014 Research and Markets  has ... Market - Global Industry Analysis, Size, Share, Growth, Trends ... http://photos.prnewswire.com/prnh/20130307/600769 ... (either DNA or RNA) into cells. This technology helps ... cells and protein metabolism by affecting the nuclear genes. ...
(Date:7/11/2014)... SEATTLE , July 11, 2014  Researchers ... navigate three-dimensional images. The new technology, called Virtual ... of small structures like neurons and synapses using ... Finger,s unique technology makes 3D imaging studies orders ... resources at an unprecedented level across many areas ...
Breaking Biology Technology:Optimizing Patient Participation in Clinical Trials: Attract. Engage. Retain. – eCongress eBox Archives Now Available 2Optimizing Patient Participation in Clinical Trials: Attract. Engage. Retain. – eCongress eBox Archives Now Available 3Optimizing Patient Participation in Clinical Trials: Attract. Engage. Retain. – eCongress eBox Archives Now Available 4Optimizing Patient Participation in Clinical Trials: Attract. Engage. Retain. – eCongress eBox Archives Now Available 52014 Nano Silver Industry in Global and China Regions Development Proposals Analysis Available at DeepResearchReports.com 22014 Nano Silver Industry in Global and China Regions Development Proposals Analysis Available at DeepResearchReports.com 3International Transfection Technology Market - Industry Analysis, Size, Share, Growth, Trends and Forecast to 2019 2Virtual Finger Enables Scientists To Navigate And Analyze 3D Images Of Complex Biological Structures 2Virtual Finger Enables Scientists To Navigate And Analyze 3D Images Of Complex Biological Structures 3
... SHANGHAI, China, Aug. 22 /Xinhua-PRNewswire-FirstCall/ --,China-Biotics, Inc. ... leading Chinese firm specializing in the manufacture,research, ... today that it has signed an agreement ... Dairy") (SSE: 600597) to supply probiotics for ...
... UniCare,s HealthWave Members with Valuable Local ... ... Health Plan of Kansas,Inc. today announced the opening of its first ... enrollees living in,the Topeka area, the CRC will provide access to ...
... - Canadian Biotechnology Company confirms commercial expression levels ... variant and clarifies status of native Apo AI ... Genetics Inc.,(TSX:SBS), a biotechnology company developing a portfolio ... updated a release,issued on July 12, 2007 announcing ...
Cached Biology Technology:China-Biotics, Inc. Signs Intention Agreement to Supply Probiotics to Bright Dairy & Food Co., Ltd. 2China-Biotics, Inc. Signs Intention Agreement to Supply Probiotics to Bright Dairy & Food Co., Ltd. 3UniCare Unveils Community Resource Center in Topeka to Serve Medicaid Enrollees 2SemBioSys updates Apo AI development program 2SemBioSys updates Apo AI development program 3SemBioSys updates Apo AI development program 4
(Date:7/14/2014)... at the University of East Anglia have shown how ... growth in cancer patients. , Research published today ... are responsible for the drug,s success in shrinking tumours. ... help develop a synthetic equivalent with anti-cancer properties. ... Complutense de Madridin, Spain. The team used samples of ...
(Date:7/13/2014)... in women suggests that experiencing one or more stressful ... can slow the body,s metabolism, potentially contributing to weight ... day,s stressors before giving them a meal consisting of ... then measured their metabolic rate how long it ... and took measures of blood sugar, triglycerides, insulin and ...
(Date:7/11/2014)... Wildlife Conservation Society shows that no-take zones in ... such as lobster, conch, and fish recover from ... areas. , The reporttitled "Review of the Benefits ... literature from no-take areas around the world. The ... recognized expert in marine protected areas and fisheries ...
Breaking Biology News(10 mins):UEA research reveals how cannabis compound could slow tumour growth 2Weighty issue: Stress and high-fat meals combine to slow metabolism in women 2Weighty issue: Stress and high-fat meals combine to slow metabolism in women 3Weighty issue: Stress and high-fat meals combine to slow metabolism in women 4Belize's lobster, conch, and fish populations rebuild in no-take zones 2
... appears to have "snipped off the ends" of its ... that infects human cells, according to research published today ... E. cuniculi , a parasitic fungus commonly found ... humans, has been widely regarded as having the smallest ...
... Global Rainmakers, Inc. (GRI), a Puerto Rico based ... today announced the appointment of James Demitrieus as Chief ... firm operations as it diversifies its product offering ... comes to GRI with over 30 years of ...
... fan out on Capitol Hill on Tuesday to engage ... to practice communicating the importance of supporting scientific discovery ... The undergraduate and graduate students participating in "Hill ... Molecular Biology, have a number of messages they intend ...
Cached Biology News:Genomic 'haircut' makes world's tiniest genome even smaller: UBC research 2Global Rainmakers Appoints James M. Demitrieus as Chief Operating Officer 2Global Rainmakers Appoints James M. Demitrieus as Chief Operating Officer 3‘Scientific leaders of the future’ gear up for important talks on Capitol Hill 2‘Scientific leaders of the future’ gear up for important talks on Capitol Hill 3
... Lines ,High Quality, Functionally-Validated, Ion Channel Cell ... for having a critical role in nerve ... key function in pain, CNS and the ... been investigated in therapeutic areas, such as ...
... PrecisION Ion Channel Cell Lines ,High ... ,Ion channels are well known for having ... function and consequently have a key function ... that modulate ion channels have been investigated ...
Mouse monoclonal antibody raised against a full length recombinant SLC25A11. NCBI Entrez Gene ID = SLC25A11...
... stains proteins in polyacrylamide gel after ... 8 ng of protein) with *CoomassieR-G250. ... processes can be performed in 1.5 ... min), proteins can be seen before ...
Biology Products: